Assistant Professor
Brigham and Women's Hospital
Boston, Massachusetts, United States
Dr. Sperling received his medical degree and PhD in Biological Chemistry from the University of California, Los Angeles in 2011. He completed his residency in internal medicine at the Brigham and Women's Hospital and his fellowship in Hematology and Oncology at the Dana-Farber Cancer Institute. He is an assistant professor of medicine at Harvard Medical School and faculty in the Division of Hematology at the Brigham and Women's Hospital and in the multiple myeloma group at the Dana-Farber Cancer Institute in Boston, MA, where he is the Associate Director of Basic and Correlative Science, Multiple Myeloma and Cell Therapies. His research focuses on understanding the mechanisms of disease evolution from pre-malignant conditions and the development of drug resistance in multiple myeloma and other hematologic malignancies.
Disclosure information not submitted.
P-252: Critical roles of LILRB4 in promoting STAT3/PIM1 mediated metabolism in multiple myeloma
Friday, September 27, 2024
6:30 PM – 6:50 PM East Coast USA Time
Friday, September 27, 2024
6:50 PM – 7:10 PM East Coast USA Time
Friday, September 27, 2024
7:10 PM – 7:30 PM East Coast USA Time